Asset

Plozasiran Sodium

Arrowhead Pharmaceuticals Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 219947NDAARROWHEAD PHARMACEUTICALS INC

Marketed products (1)

  • REDEMPLO